Orion uniquely resolves tissue microenvironments at scale, and is routinely used to develop spatial biomarkers that measure response to therapy and for unlocking mechanistic, prognostic and predictive value for patient care.
Scalable platform supporting biomarker development from validation through clinical trials
Jennifer Bordeaux, PhD
Associate Director, Digital Pathology Services, Navigate Biopharma Services, Inc.
Zhihong Chen, PhD
CTO, OCCAM Immune, Icahn School of Medicine, Mount Sinai Hospita
Yana Zavros, PhD
Professor, University of Georgia School of Medicine